As of January 22, 2025, Evolus (EOLS) has a market cap of $0.89 billion USD. According to our data, Evolus is ranked No.5365 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.89 B |
27.99%
|
Dec 31, 2024 | $0.70 B |
4.84%
|
Dec 29, 2023 | $0.67 B |
40.21%
|
Dec 30, 2022 | $0.48 B |
15.36%
|
Dec 31, 2021 | $0.41 B |
93.75%
|
Dec 31, 2020 | $0.21 B |
-72.39%
|
Dec 31, 2019 | $0.77 B |
2.27%
|
Dec 31, 2018 | $0.75 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
USA
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
Cutera
CUTR
|
$9.43 M |
0.000 M
|
USA
|
Market Cap | = | EOLS Stock Price | * | EOLS Shares Outstanding |
= | $14.13 | * | 63.32 M | |
= | $0.89 B |